Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04665843
Title	A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck (SKYSCRAPER-09)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	oropharynx cancer laryngeal squamous cell carcinoma hypopharynx cancer oral squamous cell carcinoma head and neck squamous cell carcinoma
Therapies	Atezolizumab + Tiragolumab Atezolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| FRA \| ESP